66243-1-Ig

antibody from Proteintech Group

Targeting: CA9 CAIX, MN

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

66243-1-Ig

Provider

Proteintech Group

Product name

CA9 antibody

Antibody type

Monoclonal

Description

CA9 antibody (Cat. #66243-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, mouse, pig, rabbit and has been validated for the following applications: FC, IF, IHC, WB,ELISA.

Reactivity

Human, Mouse, Porcine, Rabbit

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1G4G5

Vial size

20ul, 150ul

References

Submitted references

Alkaliptosis induction counteracts paclitaxel-resistant ovarian cancer cells via ATP6V0D1-mediated ABCB1 inhibition.

Chen F, Lin J, Kang R, Tang D, Liu J
Molecular carcinogenesis 2024 Aug;63(8):1515-1527

---

Identification of Hypoxia-Associated Signature in Colon Cancer to Assess Tumor Immune Microenvironment and Predict Prognosis Based on 14 Hypoxia-Associated Genes.

Chen P, Li Z, Liang Y, Wei M, Jiang H, Chen S, Zhao Z
International journal of general medicine 2023;16:2503-2518

---

Tumor microenvironment in a minipig model of spinal cord glioma.

Tora MS, Neill SG, Lakhina Y, Assed H, Zhang M, Nagarajan PP, Federici T, Gutierrez J, Hoang KB, Du Y, Lei K, Boulis NM
Journal of translational medicine 2023 Sep 27;21(1):667

---

ATP6V0D1 promotes alkaliptosis by blocking STAT3-mediated lysosomal pH homeostasis.

Chen F, Zhu S, Kang R, Tang D, Liu J
Cell reports 2023 Jan 31;42(1):111911

---

Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.

Liu Q, Luo Q, Feng J, Zhao Y, Ma B, Cheng H, Zhao T, Lei H, Mu C, Chen L, Meng Y, Zhang J, Long Y, Su J, Chen G, Li Y, Hu G, Liao X, Chen Q, Zhu Y
eLife 2022 Aug 1;11

---

Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer.

Zheng S, Zou Y, Liang JY, Xiao W, Yang A, Meng T, Lu S, Luo Z, Xie X
Molecular oncology 2020 Nov;14(11):2814-2833